MBX Biosciences (MBX) Research & Development (2023 - 2026)
MBX Biosciences' Research & Development was $30.99 million in Q2 2026, up 74.8% from $17.72 million a year earlier and up 67.7% from the prior quarter.
Powered by 
Analysis
MBX Biosciences (MBX) Research & Development (2023 - 2026) Analysis & Trends
On a trailing twelve-month basis, MBX Biosciences' Research & Development was $88.49 million through Jun 30, 2026, up 22.7% year-over-year; for FY2025, it was $79.16 million, up 37.9% from FY2024.
- In earlier years, Research & Development was $57.42 million in FY2024 (+101.2%) and $28.53 million in FY2023.
- The Q2 2026 figure marks the highest quarterly Research & Development in data going back to Q3 2023.
- Compared with a year earlier, Research & Development was higher in seven of the last eight quarters, with growth averaging 51.2%.
- The best year-over-year quarter for Research & Development over five years was Q1 2025 (growth of 102.8%); the worst was Q1 2026 (a decline of 17.5%).
- Per Business Quant data, MBX's Research & Development in the three quarters before Q2 2026 was $18.47 million (Q1 2026), $19.76 million (Q4 2025) and $19.27 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 993.80 Mn |
| 10 | MBX Biosciences | 2.57 Bn | 2.57 Bn | - | 30.99 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 30.99 Mn |
| Mar 31, 2026 | 18.47 Mn |
| Dec 31, 2025 | 19.76 Mn |
| Sep 30, 2025 | 19.27 Mn |
| Jun 30, 2025 | 17.72 Mn |
| Mar 31, 2025 | 22.41 Mn |
| Dec 31, 2024 | 15.22 Mn |
| Sep 30, 2024 | 16.75 Mn |
| Jun 30, 2024 | 14.40 Mn |
| Mar 31, 2024 | 11.05 Mn |
| Dec 31, 2023 | 7.73 Mn |
| Sep 30, 2023 | 9.07 Mn |
API Access
MBX Biosciences Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=MBX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "MBX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=MBX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();